Citations (18)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Dae Won Kim, Van Anh Trinh & Wen-Jen Hwu. (2014) Ipilimumab in the treatment of advanced melanoma – a clinical update. Expert Opinion on Biological Therapy 14:11, pages 1709-1718.
Read now
Read now
Hans Starz. (2012) Ipilimumab for advanced metastatic melanoma. Expert Opinion on Biological Therapy 12:8, pages 981-982.
Read now
Read now
Articles from other publishers (16)
Meng Hu, Weirong Yao & Qinglin Shen. (2022) Advances and challenges of immunocheckpoint inhibitors in the treatment of primary liver cancer. Frontiers in Genetics 13.
Crossref
Crossref
So Young Kim, Dongxu Kang, Hye Jin Choi, Yeonsoo Joo, Joo-Hang Kim & Jae J. Song. (2017) Prime-boost immunization by both DNA vaccine and oncolytic adenovirus expressing GM-CSF and shRNA of TGF-β2 induces anti-tumor immune activation. Oncotarget 8:9, pages 15858-15877.
Crossref
Crossref
Tong Zhu, James Keirns, Corrie Howieson, Atsunori Kaibara, Ronald Goldwater, Alan J. Kivitz, Vishala Chindalore, Stanley Cohen, Vicki Santos, Bolanle Akinlade, Robert Kernstock, Leticia Delgado-Herrera, Paul C Blahunka, Erik E. Karrer, Jay P. Garg, Nancy Samberg & Bernhardt G. Zeiher. (2016) Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of ASP2408, a Potent Selective T-Cell Costimulation Modulator After Single and Multiple Ascending Doses in Healthy Volunteers and RA Patients. Clinical Pharmacology in Drug Development 5:5, pages 408-425.
Crossref
Crossref
Wenhui Zhang, Robert M. Kernstock, Erik E. Karrer, Stanley B. Cohen, Vishala L. Chindalore, Alan J. Kivitz, Paul C. Blahunka, Leticia Delgado-Herrera, Bernhardt G. Zeiher, Nancy L. Samberg & Jay P. Garg. (2016) A Phase 1 Dose-Escalation Study of ASP2409, a Selective T-Cell Costimulation Inhibitor, in Stable Rheumatoid Arthritis Patients on Methotrexate Therapy. Clinical Pharmacology in Drug Development 5:4, pages 259-268.
Crossref
Crossref
Shinsuke Oshima, Erik E. Karrer, Madan M. Paidhungat, Margaret Neighbors, Steven J. Chapin, Rong A. Fan, Margaret A. Reed, Kuoting Wu, Clifford Wong, Yonghong Chen, Marc Whitlow, Francisco A. Anderson, Rujuta A. Bam, Qian Zhang, Brent R. Larsen, Sridhar Viswanathan, Bruce H. Devens, Steven H. Bass & Yasuyuki Higashi. (2016) ASP2408 and ASP2409, novel CTLA4-Ig variants with CD86-selective ligand binding activity and improved immunosuppressive potency, created by directed evolution. Protein Engineering Design and Selection 29:5, pages 159-167.
Crossref
Crossref
Meng‑Hua Dong, Qian Zhang, Yuan‑Yuan Wang, Bai‑Sui Zhou, Yu‑Fei Sun & Qiang Fu. (2016) Euphorbia fischeriana Steud inhibits malignant melanoma via modulation of the phosphoinositide-3-kinase/Akt signaling pathway. Experimental and Therapeutic Medicine.
Crossref
Crossref
Gabriel Gazzé. (2015) Pharmacist's role in optimizing therapy of the newer agents for the treatment of metastatic melanoma. Melanoma Management 2:1, pages 75-82.
Crossref
Crossref
Peter L. Stern. 2015. Cancer Immunology. Cancer Immunology
409
425
.
Anthony JarkowskiIIIIII, LeAnn Norris & Van Anh Trinh. (2014) Controversies in the Management of Advanced Melanoma. Annals of Pharmacotherapy 48:11, pages 1456-1468.
Crossref
Crossref
Hans Starz. (2014) Von der OP bis zur Immuntherapie. MMW - Fortschritte der Medizin 156:4, pages 41-44.
Crossref
Crossref
David Escors. (2014) Tumour Immunogenicity, Antigen Presentation, and Immunological Barriers in Cancer Immunotherapy. New Journal of Science 2014, pages 1-25.
Crossref
Crossref
Howard L. Kaufman, John M. Kirkwood, F. Stephen Hodi, Sanjiv Agarwala, Thomas Amatruda, Steven D. Bines, Joseph I. Clark, Brendan Curti, Marc S. Ernstoff, Thomas Gajewski, Rene Gonzalez, Laura Jane Hyde, David Lawson, Michael Lotze, Jose Lutzky, Kim Margolin, David F. McDermott, Donald Morton, Anna Pavlick, Jon M. Richards, William Sharfman, Vernon K. Sondak, Jeffrey Sosman, Susan Steel, Ahmad Tarhini, John A. Thompson, Jill Titze, Walter Urba, Richard White & Michael B. Atkins. (2013) The Society for Immunotherapy of Cancer consensus statement on tumour immunotherapy for the treatment of cutaneous melanoma. Nature Reviews Clinical Oncology 10:10, pages 588-598.
Crossref
Crossref
Helena Wållberg & Stefan Ståhl. (2013) Design and evaluation of radiolabeled tracers for tumor imaging. Biotechnology and Applied Biochemistry 60:4, pages 365-383.
Crossref
Crossref
Guido Wollmann, John N. Davis, Marcus W. Bosenberg & Anthony N. van den Pol. (2013) Vesicular Stomatitis Virus Variants Selectively Infect and Kill Human Melanomas but Not Normal Melanocytes. Journal of Virology 87:12, pages 6644-6659.
Crossref
Crossref
Mahsa A. Sohrab, Rajen U. Desai, Christopher B. Chambers & Gary S. Lissner. (2013) Re. Ophthalmic Plastic & Reconstructive Surgery 29:3, pages 239-240.
Crossref
Crossref
V. Sibaud & C. Robert. (2013) Anomalies pigmentaires induites par les traitements anticancéreux. Deuxième partie : les thérapies ciblées. Annales de Dermatologie et de Vénéréologie 140:4, pages 266-273.
Crossref
Crossref